The United Kingdom's (UK) health secretary, Matt Hancock, on Wednesday said that AstraZeneca had submitted a full data package about its Covid-19 vaccine to the Medicines and Healthcare products Regulatory Agency (MHRA) for approval.
"I'm delighted that the University of Oxford/ AstraZeneca vaccine, developed in the UK, has submitted its full data package to the MHRA for approval. This is the next step towards a decision on the deployment of the coronavirus vaccine," Matt Hancock, UK Health Minister wrote in a tweet.
"Amid all of this difficulty, the great hope for 2021 is of course on the vaccine," he said.
He further stated, "This is the next step towards a decision on the deployment of the vaccine, which is already being manufactured including here in the UK."
We are of course continuing to deploy the Pfizer/BioNTech vaccine, which is being delivered now from over 500 sites all across the UK, and we're adding more all of the time and accelerating the roll-out," Hancock added.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)